WC
HAE icon

Walthausen & Co’s Haemonetics HAE Stock Holding History

Walthausen & Co’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.42M Sell
19,226
-11,340
-37% -$814K 1.19% 31
2022
Q2 		$1.99M Sell
30,566
-4,460
-13% -$264K 0.89% 32
2022
Q1 		$2.21M Buy
+35,026
New +$1.9M 0.62% 95

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walthausen & Co's HAE Position: Q3 2022 in Review

Walthausen & Co reduced its Haemonetics (HAE) stake by 37% in Q3 2022, selling an estimated $814K and leaving 19,226 shares worth $1.42M. The position accounts for 1.19% of the portfolio, ranked #31.

Walthausen & Co first reported a position in HAE in Q1 2022 and has held it in 3 quarters since. The position peaked at $2.21M in Q1 2022. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2022.

  • Walthausen & Co held 19,226 shares of Haemonetics worth $1.42M as of Q3 2022.
  • Walthausen & Co sold 11,340 Haemonetics shares in Q3 2022, an estimated $814K.
  • Haemonetics made up 1.19% of Walthausen & Co's portfolio in Q3 2022, its #31 holding.
  • Walthausen & Co first reported a position in Haemonetics in Q1 2022 and has held it in 3 quarters since.
  • Walthausen & Co's Haemonetics position peaked at $2.21M in Q1 2022.
  • 268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2022.

Based on Walthausen & Co's 13F filing for Q3 2022, filed 14 Nov 2022.